Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|8|7|709-715

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.8, Iss.7, 2007-10, pp. : 709-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

E2F1-Mediated Apoptosis as a Target of Cancer Therapy

By  

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 149-160

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the p53 Pathway of Apoptosis

By  

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2493-2503

Bentham Science Publishers

Access to resources Recommend Favorite

COMPLEX INTERPLAY AMONG APOPTOSIS FACTORS: RB, P53, E2F, TGF-beta, CELL CYCLE INHIBITORS AND THE BCL2 GENE FAMILY

By Chiarugi V.   Magnelli L.   Cinelli M.  

Pharmacological Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 257-261

Academic Press

Access to resources Recommend Favorite

The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer

By Crosby Colin G   DuBois Raymond N  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

UVB-induced experimental carcinogenesis: dysregulation of apoptosis and p53 signalling pathway

By Ouhtit A.   Konrad Muller H.   Gorny A.   Ananthaswamy H.N.  

Redox Report, Vol. 5, Iss. 2-3, 2000-04 ,pp. : 128-129

Maney Publishing

Access to resources Recommend Favorite